These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24939178)

  • 1. Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells.
    Zhang D; Cui Y; Niu L; Xu X; Tian K; Young CY; Lou H; Yuan H
    Eur J Cell Biol; 2014 Jul; 93(7):289-98. PubMed ID: 24939178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
    Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
    Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.
    Zhang T; Shen H; Dong W; Qu X; Liu Q; Du J
    Sci Rep; 2014 Oct; 4():6855. PubMed ID: 25358597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.
    Zheng H; Shen H; Oprea I; Worrall C; Stefanescu R; Girnita A; Girnita L
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20620-5. PubMed ID: 23188799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.
    Suleymanova N; Crudden C; Shibano T; Worrall C; Oprea I; Tica A; Calin GA; Girnita A; Girnita L
    Oncogene; 2017 Oct; 36(41):5734-5744. PubMed ID: 28581517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
    Cao H; Dong W; Shen H; Xu J; Zhu L; Liu Q; Du J
    PLoS One; 2015; 10(8):e0135844. PubMed ID: 26287334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
    Ma Y; Cheng Q; Ren Z; Xu L; Zhao Y; Sun J; Hu S; Xiao W
    Cancer Lett; 2012 Apr; 317(2):150-6. PubMed ID: 22115966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
    Choi JM; Jang JY; Choi YR; Kim HR; Cho BC; Lee HW
    Lung Cancer; 2015 Nov; 90(2):175-81. PubMed ID: 26342551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.
    Jones HE; Goddard L; Gee JM; Hiscox S; Rubini M; Barrow D; Knowlden JM; Williams S; Wakeling AE; Nicholson RI
    Endocr Relat Cancer; 2004 Dec; 11(4):793-814. PubMed ID: 15613453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling.
    Choi JS; Paek AR; Kim SY; You HJ
    Cancer Lett; 2010 Aug; 294(2):254-63. PubMed ID: 20206441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Vasilcanu D; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2007 Apr; 282(15):11329-38. PubMed ID: 17303558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
    Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
    Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3.
    Hu F; Zhao Y; Yu Y; Fang JM; Cui R; Liu ZQ; Guo XL; Xu Q
    Cancer Lett; 2018 Mar; 416():24-30. PubMed ID: 29246644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels.
    Tang Y; Parmakhtiar B; Simoneau AR; Xie J; Fruehauf J; Lilly M; Zi X
    Neoplasia; 2011 Feb; 13(2):108-19. PubMed ID: 21403837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
    Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
    Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.
    Bodzin AS; Wei Z; Hurtt R; Gu T; Doria C
    J Cell Physiol; 2012 Jul; 227(7):2947-52. PubMed ID: 21959795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation.
    Lecosnier S; Cordier C; Simon P; François JC; Saison-Behmoaras TE
    FASEB J; 2011 Jul; 25(7):2201-10. PubMed ID: 21402719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
    Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
    Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.